An additional patient with mycophenolate mofetil embryopathy: Cardiac and facial analyses

American Journal of Medical Genetics, Part A

Volumn 155, Issue 4, 2011, Pages 748-756

  Lin, Angela E ^a   Singh, Kathryn E ^b   Strauss, Arthur ^c   Nguyen, Son ^c   Rawson, Kristyn ^b   Kimonis, Virginia E ^b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MILLER CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular malformation; Congenital heart defect; Conotruncal; Microtia; Mycophenolate mofetil; Teratogen

Indexed keywords

ACICLOVIR; ADALIMUMAB; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; FELODIPINE; FERROUS SULFATE; HYDROXYCHLOROQUINE; IRBESARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEPRAZOLE; PREDNISONE; TACROLIMUS;

ADULT; AMNIOCENTESIS; ANEMIA; AORTA ARCH ANOMALY; ARTICLE; CAMBODIA; CESAREAN SECTION; CLINICAL ARTICLE; COLOBOMA; CONCEPTION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; CRYPTORCHISM; DISEASE SEVERITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EMBRYOPATHY; EMBRYOTOXICITY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GASTROSTOMY; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HEART VENTRICLE SEPTUM DEFECT; HEMIFACIAL MICROSOMIA; HUMAN; HUMAN CELL; HYPOPLASIA; INFANT; MALE; MATERNAL SERUM; MICROGNATHIA; MICROPHTHALMIA; MICROTIA; MUSCLE HYPOTONIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEURAL CREST CELL; PRIORITY JOURNAL; PULMONARY ARTERY STENOSIS; RESPIRATORY FAILURE; SUICIDE; TRACHEOSTOMY; TRISOMY 13;

FACE; FEMALE; FETAL DISEASES; HEART DEFECTS, CONGENITAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PHENOTYPE; PREGNANCY;

EID: 79953324901     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33934     Document Type: Article

References (34)

1. Amiel J, Attieé-Bitach T, Marianowski R, Cormier-Daire V, Abadie V, Bonnet D, Gonzales M, Chemouny S, Brunelle F, Munnich A, Manach Y, Lyonnet S. 2001. Temporal bone anomaly proposed as a major criteria for diagnosis of CHARGE syndrome. Am J Med Genet 99: 124-127.
2. Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA. 2009. Reviewing the evidence for mycophenolate mofetil as a new teratogen: Case report and review of the literature. Am J Med Genet Part A 149A: 1241-1248.
3. Andrade Vila JH, da Silva JP, Guilhen CJ, Baumgratz JF, da Fonseca L. 2008. Even low dose of mycophenolate mofetil in a mother recipient of heart transplant can seriously damage the fetus. Transplantation 86: 369-370.
4. Ang GS, Simpson SA, Reddy AR. 2008. Mycophenolate mofetil embryopathy may be dose and timing dependent. Am J Med Genet Part A 146A: 1963-1966.
5. Armenti VT, Radomski JS, Moritz MJ, Gaughan WJ, Hecker WP, Lavelanet A, McGrory CH, Coscia LA. 2004. Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. In: Cecka JM, Terasaki PI, editors. Clinical transplants 2004. Los Angeles, CA: UCLA Immunogenetics Center. pp. 103-114.
6. Carey JC. 2008. Where observation is concerned, chance favors only the prepared mind. Obstet Gynecol 111: 479-480.
7. Dei Malatesta MF, Rocca B, Gentile T, Hadjistilianou M, Borri M, de Francesco S, Pisani F, Famulari A. 2009. A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. Transplant Proc 41: 1407-1409.
8. El Sebaaly Z, Charpentier B, Snanoudj R. 2007. Fetal malformations associated with mycophenolate mofetil for lupus nephritis. Nephrol Dial Transplant 22: 2722.
9. Heike CL, Hing AV. 2010. Craniofacial microsomia overview. GeneReviews. Posted March 19, 2009. Accessioned September 9, 2010.
10. Horgan JE, Padwa BL, LaBrie RA, Mullken JB. 1995. OMENS-Plus: analysis of craniofacial and extracraniofacial anomalies in hemifacial microsomia. Cleft Palate Craniofac J 32: 405-412.
11. Huang SY, Chueh HY, Shaw SW, Shih JC, Cheng PJ. 2008. Sonographic diagnosis of fetal malformations associated with mycophenolate mofetil exposure in utero. Am J Obstet Gynecol 199: e6-e8.
12. Hunter A, Frias JL, Gillessen-Kaesbach G, Hughes H, Jones KL, Wilson L. 2009. Elements of morphology: Standard terminology for the ear. Am J Med Genet Part A 149A: 40-60.
13. Jackson P, Paquette L, Watiker V, Randolph L, Ramanathan R, Seri I. 2009. Intrauterine exposure to mycophenolate mofetil and multiple congenital anomalies in a newborn: Possible teratogenic effect. Am J Med Genet Part A 149A: 1231-1236.
14. Källén B, Westgren M, Aberg A, Olausson OP. 2005. Pregnancy outcome after maternal organ transplantation in Sweden. Br J Obstet Gynaecol 112: 904-909.
15. Klieger-Grossman C, Chitayat D, Lavign S, Kao K, Garcia-Bournissen F, Quinn D, Luo V, Sermer M, Riordan S, Laskein C, Matok I, Gorodischer R, Chambers C, Levi A, Koren G. 2010. Prenatal exposure to mycophenolate mofetil: An updated estimate. JOGC 32: 794-797.
16. Koshy AN, Strong D, Earles G, Fassett RG. 2010. Congenital malformations with low-dose mycophenolate mofetil after kidney transplantation. Nephrology 15: 133-135.
17. Lammer EJ. 1991. Preliminary observations on isoretinoin-induced ear malformations and pattern formation of the external ear. J Craniofac Genet Dev Biol 11: 292-295.
18. Le Ray C, Coulomb A, Elefant E, Frydman R, Audibert F. 2004. Mycophenolate mofetil in pregnancy after renal transplantation: A case of major fetal malformations. Obstet Gynecol 103: 1091-1094.
19. Lin AE, Belmont J, Ghaffar S. 2006. The heart. In: Stevenson RE, Hall JG, editors. Human malformations and related anomalies, 2nd edition. New York: Oxford University Press. pp. 85-120.
20. Merlob P, Stahl B, Klinger K. 2009. Tetrada of the possible mycophenolate mofetil embryopathy: A review. Repro Toxicol 28: 105-108.
21. Milunsky JM, Maher TM, Zhao G, Wang Z, Mulliken JB, Chitayat D, Clemens M, Stalker HJ, Bauer M, Burch M, Chénier S, Cunningham ML, Drack AV, Janssens S, Karlea A, Klatt R, Kini U, Klein O, Lachmeijer AM, Megarbane A, Mendelsohn NJ, Meschino WS, Mortier GR, Parkash S, Ray CR, Roberts A, Roberts A, Reardon W, Schnur RE, Smith R, Splitt M, Tezcan K, Whiteford ML, Wong DA, Zori R, Lin AE. 2010. Genotype-phenotype analysis of the branchio-oculo-facial syndrome. Am J Med Genet A 155A: 22-32.
22. Obler D, Juraszek AL, Smoot LB, Natowicz MR. 2008. Double outlet right ventricle: Aetiologies and associations. J Med Genet 45: 481-497.
23. Parisi MA, Zayed H, Slavotinek AM, Rutledge JC. 2009. Congenital diaphragmatic hernia and microtia in a newborn with mycophenolate mofetil (MMF) exposure: Phenocopy for Fryns syndrome or broad spectrum of teratogenic effects? Am J Med Genet Part A 149A: 1237-1240.
24. Passos-Bueno MR, Ornelas CC, Fanfaniello RD. 2009. Syndromes of the first and second pharyngeal arches: A review. Am J Med Genet Part A 149A: 1853-1859.
25. Perez-Aytes A, Ledo A, Boso V, Saenz P, Roma E, Poveda JL, Vento M. 2008. In utero exposure to mycophenolate mofetil: A characteristic phenotype? Am J Med Genet Part A 146A: 1-7.
26. Pérgola PE, Kancharla A, Riley DJ. 2001. Kidney transplantation during the first trimester of pregnancy: Immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. Transplantation 71: 994-997.
27. Schoner K, Steinhard J, Figiel J, Rehder H. 2008. Severe facial clefts in acrofacial dystosis: A consequence of prenatal exposure to mycophenolate mofetil? Obstet Gynecol 111: 483-486.
28. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet A, Moritz MJ, Armenti VT. 2006. Pregnancy outcomes in solid organ transplant with exposure to mycophenolate mofetil or sirolimus. Transplantation 82: 1698-1702.
29. Stoetzel C, Riehm S, Bennouna Greene V, Pelletier V, Vigneron J, Leheup B, Marion V, Hellé S, Danse JM, Thibault C, Moulinier L, Veillon F, Dollfus H. 2009. Confirmation of TFAP2A gene involvement in branchio-oculo-facial syndrome (BOFS) and report of temporal bone anomalies. Am J Med Genet A 149A: 2141-2146.
30. Tekin M, Sirmaci A, Yüksel-Konuk B, Fitoz S, Sennaroǧlu L. 2009. A complex TFAP2A allele is associated with branchio-oculo-facial syndrome and inner ear malformation in a deaf child. Am J Med Genet A 149A: 427-430.
31. Tjeertes IF, Bastiaans DE, van Ganzewinkel CJ, Zegers SH. 2007. Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use. J Perinatol 27: 62-64.
32. Velinov M, Zellers N. 2008. The fetal mycophenolate mofetil syndrome. Clin Dysmorphol 17: 77-78.
33. Vento RA, LaBrie RA, Mulliken JB. 1991. The O.M.E.N.S. classification of hemifacial microsomia. Cleft Palate Craniofac J 28: 68-76.
34. Vento M, Perez-Aytes A, Ledo A, Boso V, Carey JC. 2008. Mycophenolate mofetil during pregnancy: Some words of caution. Pediatrics 122: 184-185.